Healthcare systems have sharpened their focus on detecting, preventing, and reporting drug diversion, yet many programs that appear strong on paper still reveal critical gaps in practice.
In this session, seasoned drug diversion investigator Russ Nix guided attendees through a diagnostic assessment of their program's effectiveness using a four-stage maturity model built around the Three Ps of Prevention: Policy, Personnel, and Platform.
Participants explored what separates a reactive program from a mature one and identified the specific gaps holding their organizations back. They gained actionable strategies and a practical roadmap for closing the distance between their current state and a more effective, compliant drug diversion prevention program.
Learning objectives
- Assessed their program's maturity stage across Policy, Personnel, and Platform.
- Identified gaps between written policy and everyday practice that increase organizational risk.
- Prioritized next steps in education, oversight, regulation, and technology to advance program maturity.
- Applied targeted improvements and best practices to support higher levels of compliance and effectiveness.